𝕏
Latest

Author

Imogen Reyes

Senior writer, legal and rare disease markets

Imogen Reyes covers pharmaceutical litigation, settlements and patent disputes for PharmaWire, and writes its long-form rare disease market guides.

Latest from Imogen Reyes

Legal

Merz Wins Appeal to Block Generic MS Drug Sales in France

Pharmaceutical company Merz has secured a key legal victory in its ongoing dispute over its multiple sclerosis drug Fampyra. The Court of Appeal of the Unified Patent Court (UPC) has overturned an earlier decision and granted a preliminary…